Diane Hanna, DNP, DCNP, FAANP

Vice President, Medical Affairs

Diane Hanna (“Hanna”) was promoted to vice president, medical affairs in March 2024; she joined Arcutis in 2021 and has held roles of increasing responsibility within the organization, initially serving as principal medical science liaison and shortly thereafter being promoted to executive medical director, where she was responsible for shaping and executing medical strategy. Prior to Arcutis, Dr Hanna served as senior medical science liaison, most recently at Sanofi Genzyme (dupilumab) and Celgene (apremilast). Dr Hanna’s focus and area of expertise is pre-FDA approval where she launched more than a dozen therapies in the topical, oral, and biologic space over her decades of experience. Throughout this entire time, Dr Hanna has continued to take care of dermatology patients—she is the director of clinical research at Modern Dermatology, where she specializes in the care of patients with atopic dermatitis. Dr Hanna has held numerous leadership positions, including Society of Aesthetic Injectors (SAI) board president and the Society of Dermatology Nurse Practitioners (SDNP), as one of the founding members, board member, and past president. She is an author of numerous scientific papers in the field of dermatology. Dr Hanna earned her DNP, MSN, and BSN from The University of Kansas. She is a board-certified Dermatology-Certified Nurse Practitioner and Family Nurse Practitioner as well as a fellow of the American Association of Nurse Practitioners and a fellow of the Society of Dermatology Nurse Practitioners.